TY - JOUR
T1 - Management of chronic subdural hematoma
T2 - Part I – Pathogenesis and diagnosis
AU - Verploegh, Iris
AU - Volovici, Victor
AU - Dammers, R.
AU - Berghauser Pont, Lotte
PY - 2015/1/30
Y1 - 2015/1/30
N2 - Chronic subdural hematoma (CSDH) is a common condition in neurosurgical practice. A CSDH is defined as an “old” collection of blood and blood breakdown products in the subdural space, developing over a period of longer than 14 days. CSDH has a high prevalence, ranging from 1.72 per 100,000 in the general population to 58 per 100,000 in the elderly (≥65 years). Because of an aging global population, the prevalence of CSDH is expected to increase. Moreover, the use of anticoagulants and antiplatelet treatment for cardiovascular problems, which is an important risk factor for developing CSDH, is increasing. Although CSDH is well treated with burr-hole craniostomy or conservative modalities in selected cases, the mortality rate after 1 year is as high as 32%. Therefore, early diagnosis and adequate treatment are essential. In part I of this review, we discuss the pathophysiology and diagnosis of CSDH. In part II, we present treatment options and the most important determinants of disease outcome in patients with CSDH.
AB - Chronic subdural hematoma (CSDH) is a common condition in neurosurgical practice. A CSDH is defined as an “old” collection of blood and blood breakdown products in the subdural space, developing over a period of longer than 14 days. CSDH has a high prevalence, ranging from 1.72 per 100,000 in the general population to 58 per 100,000 in the elderly (≥65 years). Because of an aging global population, the prevalence of CSDH is expected to increase. Moreover, the use of anticoagulants and antiplatelet treatment for cardiovascular problems, which is an important risk factor for developing CSDH, is increasing. Although CSDH is well treated with burr-hole craniostomy or conservative modalities in selected cases, the mortality rate after 1 year is as high as 32%. Therefore, early diagnosis and adequate treatment are essential. In part I of this review, we discuss the pathophysiology and diagnosis of CSDH. In part II, we present treatment options and the most important determinants of disease outcome in patients with CSDH.
UR - https://www.semanticscholar.org/paper/Management-of-Chronic-Subdural-Hematoma%3A-Part-and-Verploegh-Volovici/ab44bbaaf66b7ac42e1d46c2667204139a4caeae
U2 - 10.1097/01.cne.0000463872.19592.a5
DO - 10.1097/01.cne.0000463872.19592.a5
M3 - Article
SN - 0163-2108
VL - 37
JO - Contemporary Neurosurgery
JF - Contemporary Neurosurgery
IS - 2
ER -